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onstantinos Tsagakis, MD,† Hilmar Kühl, MD,§ Sebastian Huptas, MD,*
uido Gerken, MD,‡ Heinz G. Jakob, MD,† Raimund Erbel, MD*
ssen, Germany; and Durham, North Carolina
bjectives Our goal was to report characteristics and outcomes of 6 patients with aortoesophageal
stula (AEF) after thoracic endovascular aortic repair (TEVAR).
ackground Neurologic events are severe complications of TEVAR. With growing experience of
EVAR, other yet unexpected devastating complications have emerged.
ethods Between July 1999 and August 2008, 268 patients underwent TEVAR for various thoracic
ortic diseases at our institution.
esults Six of 268 patients (age 49 to 77 years, 50% female patients) developed AEF (incidence
.9%) within 1 to 16 months after the procedure. Indications for TEVAR were acute aortic dissection
n  3), chronic aortic dissection (n  1), and thoracic aortic aneurysm (n  2). Four patients pre-
ented with sudden massive hematemesis whereas 2 patients were readmitted for new-onset fever
nd elevated markers of inﬂammation that preceded hematemesis. Esophago-gastro-duodenoscopy
dentiﬁed deep esophageal ulcerations at the level of the implanted aortic stent-graft in 4 patients,
ut only mild erosive lesions within the proximal esophagus without signs of active bleeding in the
emaining 2 patients. Surgical repair was performed in only 1 patient and declined in the remaining
ecause of comorbidities and multiorgan system failure. Despite this, all patients died due to fatal
ebleeding (n  4) or mediastinitis (n  2).
onclusions AEF is a rare and unusual complication of TEVAR that occurs relatively early after the
rocedure and is almost invariably fatal. New-onset fever with elevated inﬂammatory markers or
ematemesis should heighten clinical suspicion of AEF in TEVAR patients and prompt computed
omography or esophago-gastro-duodenoscopy in the hope of detecting, triaging, and treating this
arly to improve the otherwise dismal outcomes of these patients. (J Am Coll Cardiol Intv 2009;2:
70–6) © 2009 by the American College of Cardiology Foundation
rom the *Department of Cardiology and the †Department of Cardiothoracic Surgery, West-German Heart Center Essen, Essen,
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571horacic endovascular aortic repair (TEVAR) is increas-
ngly applied in clinical practice as a novel, less invasive
reatment for patients with aortic aneurysms and dissec-
ions, particularly in patients deemed at high-risk for
onventional surgical repair (1,2). Observational nonran-
omized data suggest that the risk of acute complications of
EVAR, most notably paraplegia and stroke, appears to
ompare favorably with open surgery (3–5). Mid-term and
ong-term complications remain less well defined, and—as
ith any new technology—TEVAR bears the risk of
nusual, previously unanticipated complications, which are
nly detected by a high level of clinical suspicion and
urveillance as experience and use of this technology in-
reases (6). In our early experience, we have reported 3
atients who developed sudden massive hematemesis due to
ortoesophageal fistula (AEF) formation secondary to
EVAR (7). While TEVAR continues to be increasingly
mbraced, many patients treated with this technique will be
ared for by physicians in the community at large. Both
nterventionalists and general physicians are generally un-
ware of AEF as an important but rather rare differential
iagnosis of hematemesis or other symptoms among other
ore common etiologies in patients with prior TEVAR.
ncreasing awareness of this complication may facilitate
apid diagnosis and/or triage and treatment. Accordingly,
he goal of the current report is to summarize our experience
ith the presentation, diagnostic approach, management,
nd outcomes of this unusual, but catastrophic, complica-
ion of TEVAR and to increase its familiarity within the
nterventional community.
ethods
atients. Between July 30, 1999, and August 25, 2008, a
otal of 213 patients (70% men, median age 67.5 years,
ange 22 to 87 years) underwent retrograde transfemoral/
ransiliac TEVAR at our institution. Additionally, 55 pa-
ients (71% men, median age 60 years, range 34 to 78 years)
nderwent antegrade stent-grafting of the descending tho-
acic aorta (DTA) during open ascending aortic or arch
urgery. After TEVAR, all patients were subjected to a strict
ollow-up protocol, including clinical assessment and imag-
ng of the aorta before discharge, as well as at 3, 6, or 12
onths, and then annually after the procedure. Follow-up
nformation was available for all but 2 patients (99%) who
nderwent TEVAR with a median follow-up of 13.0
interquartile range 2.6 to 41.8) months.
Patients readmitted for AEF were identified from our
nstitutional aortic stent-graft database. All patients’ charts
nd records were thoroughly reviewed. Symptoms and
aboratory status at readmission, clinical management, com-
lications during further course, as well as date and cause of
eath were noted. All implantation angiographies and womputed tomography (CT) scans of the patients were
eviewed in order to identify anatomic similarities among
he patients potentially predisposing to AEF formation.
rom angiography, the proximal landing zone of the stent-
raft was assessed dividing the aortic arch in 4 zones as
reviously described (8). All CTs were reviewed by experi-
nced radiologists. The maximum diameter of the proximal
ortic landing zone was measured. The DTA was evaluated
ualitatively for the presence of significant elongation or
re-vertebral course. Elongation was present when the
hape of the DTA was not round on the axial CT images,
ut significantly oval shaped, and the aorta took a deep
eft-lateral course in relation to the spine. The CT at
eadmission was evaluated for the presence of endoleakage.
tatistical analysis. Categorical data are presented as fre-
uencies; continuous variables are expressed as median and
ange.
esults
mong 268 patients undergoing
etrograde or antegrade TEVAR
t our institution during the
tudy period, AEF occurred in 5
1.9%) (Table 1). One additional
ale patient (49 years) who un-
erwent TEVAR at an external
nstitution was admitted to our
nstitution with AEF. Median
ge of these patients was 64.5
range 49 to 77) years with one-
alf being men. Procedural data
re given in Table 2. A 77-year-
ld female patient presented
ith ruptured thoracic aortic an-
urysm (TAA) and penetration into the esophagus.
AEF occurred median 2.4 (1 to 16) months after
EVAR. Four of the 6 (67%) patients presented with
udden hematemesis. The remaining 2 patients were pri-
arily readmitted for new-onset fever and elevated inflam-
atory laboratory parameters, but both developed massive
ematemesis after 2 and 20 days, respectively.
CT angiography showed—similarly for all patients—new
onhomogenous masses between aorta and esophagus (Fig.
). Air entrapment suggestive of esophageal perforation and
ediastinitis was observed in 4 of 6 patients. Right-sided
leural effusion was present in one-half of the patients.
sophago-gastro-duodenoscopy (EGD) identified deep
sophageal ulcerations at the level of the implanted aortic
tent-graft in 4 patients (Fig. 2). In these patients, EGD
howed large defects of the esophageal wall, allowing direct
iew of the aortic stent-graft (Fig. 3). In the remaining 2
atients, mild erosive lesions within the proximal esophagus
Abbreviations
and Acronyms
AEF  aortoesophageal
fistula
CT  computed tomography
DTA  descending thoracic
aorta
EGD  esophago-gastro-
duodenoscopy
TAA  thoracic aortic
aneurysm
TEVAR  thoracic
endovascular aortic repairithout signs of active bleeding were observed. In both
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572atients, the presence of AEF behind this mild erosive
esion was not recognized at first presentation and the first
atient was even discharged after a few days. He developed
atal hematemesis within 14 days, and definitive diagnosis of
EF was made only at necropsy. In the other female patient
Table 1. Patient Data
Patient,
Age,
Gender
Aortic
Disease
Date of
TEVAR
Date of
Readmission
for AEF
Symptoms at
Readmission
Lab
at
H.K., 62 yrs,
male
AD May 17,
2001
June 19,
2001
New-onset fever,
back pain
He
Le
CR
Fib
D-
I.L., 74 yrs,
female
TAA January 28,
2002
October 25,
2002
New-onset fever He
Le
CR
Fib
D-
H.P., 77 yrs,
female
Ruptured
TAA‡
April 24,
2002
July 6, 2002 Hematemesis, fever He
Le
CR
Fib
D-
W.K., 67
yrs,
female
AAD October 24,
2005§
February 22,
2007
Hematemesis, fever He
Le
CR
Fib
D-
R.G., 49 yrs,
male
AAD February 23,
2006
April 24,
2006
Hematemesis He
Le
CR
Fib
D-
H.T., 52 yrs,
male
AAD May 30,
2007
October 8,
2007
Hematemesis Hem
Leu
CRP
Fibr
D-d
*Units for laboratory markers: hemoglobin (g/dl); leukocytes (/nl); C-reactive protein (CRP) (mg/dl,
acute type B dissection with contained rupture; ‡definitive diagnosis was made only at necropsy; §
ascending aortic replacement for acute type A dissection.
AAD acute aortic dissection; AEF aortoesophageal fistula; PEG percutaneous endoscopic
Table 2. Stent-Graft and CT Analysis Data
Patient, Age,
Gender
Maximum
Diameter of
the Proximal
Landing Zone
Stent-Graft
Diameter
(mm)
Number of
Stent-Grafts
Implanted
H.K., 62 yrs, male 32 38 1
I.L., 74 yrs, female 36 42 3
H.P., 77 yrs, female 30 34 1
W.K., 67 yrs, female 24* 24 1
R.G., 49 yrs, male 35 38 2
H.T., 52 yrs, male 31 32 2
*Surgical ascending aortic replacement for acute type A dissection with 24-mm prosthesis.AEF aortoesophageal fistula; CT computed tomography.ho underwent antegrade stent-grafting, hematemesis was
uspected to be associated with endoleakage, and the patient
nderwent re-TEVAR. Three months later, the patient
resented again with hematemesis and now large AEF
ecame evident on EGD.
y Markers
mission* Treatment
Complications
During Hospital
Course
Date of
Death
Cause of
Death
bin: 10.3
es: 11.2
n: 1,000
: —
Antibiotics† Hematemesis September
7, 2001
Fatal
rebleeding
bin: 10.7
es: 29.3
n: 869
: 489
PEG, antibiotics Mediastinitis,
hematemesis
August 11,
2002
Mediastinitis
bin: 7.9
es: 21.1
n: 933
: 340
Esophageal stent
implantation,
PEG, antibiotics
Mediastinitis,
rebleeding
January
30,
2003
Fatal
rebleeding
bin: 8.9
es: 10.9
n: 749
: —
Re-TEVAR, PEG,
antibiotics
Mediastinitis,
rebleeding
October 1,
2007
Mediastinitis
bin: 6.8
es: 16.5
n: 686
: 446
Surgical stent-graft
explantation,
redo surgery for
mediastinitis,
esophageal
stent implantation,
PEG, antibiotics
Mediastinitis June 17,
2006
Fatal
rebleeding
in: 8.7
s: 18.3
: 412
624
Esophageal stent
implantation,
PEG, antibiotics
Rebleeding October 2,
2007
Fatal
rebleeding
0.5); fibrinogen (mg/dl); D-dimers (g/ml, normal250); †performed at an external hospital for
netration into the esophagus; surgical antegrade stent-graft placement via the open arch during
tomy; TAA thoracic aortic aneurysm; TEVAR thoracic endovascular aortic repair.
imal Aortic
ding Zone
Elongation of
Descending
Thoracic Aorta
Pre- or Right-Vertebral
Course of the
Descending
Thoracic Aorta
Endoleak
at the Time
of AEF
2 No No No
2 Yes Yes Yes
3 No No No
2 Yes No Yes
2 No No No
1 Yes Yes Noorator
Read
moglo
ukocyt
P: 25.1
rinoge
dimers
moglo
ukocyt
P: 20.5
rinoge
dimers
moglo
ukocyt
P: 24.5
rinoge
dimers
moglo
ukocyt
P: 13.1
rinoge
dimers
moglo
ukocyt
P: 14.6
rinoge
dimers
oglob
kocyte
: 18.4
inogen
imers:
normal
with peProx
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573In patients undergoing emergency EGD for massive
ematemesis, placement of a Sengstaken-Blakemore tube
n  1) or self-expanding esophageal stents (n  2) was
erformed to control bleeding. Surgical repair was per-
ormed in a single patient, and was contemplated in an-
ther. In the remaining patients, surgery was refused due to
heir reduced general health condition. During surgery, the
tent-graft was explanted and replaced by a Dacron graft.
he post-operative course was complicated by mediastinitis
equiring revision surgery. Conservative management was
pplied in the remaining 5 patients and included use of
road-spectrum antibiotics and proton pump inhibitor
reatment, as well as percutaneous endoscopy-guided gas-
rostomy to unburden the esophageal lesion. Covered self-
xpanding metallic stents were implanted into the esopha-
us in 3 of 6 patients to prevent recurrent bleeding and
romote healing of the ulcer site. However, healing of the
lcer was not observed in any of these patients, despite
eaving the esophageal stent in place for up to 4 weeks. In
A B
D E
Figure 1. CT Images of Patients at Presentation
Contrast-enhanced computed tomography (CT) scans of the 6 patients (A to F
dence of new nonhomogenous masses between the aorta and esophagus (as
B to F (arrows). Ao  descending thoracic aorta.he female patient who presented with a ruptured TAA, the osophageal lesion did not show any signs of healing, but the
lcer had, in fact, progressed in size.
The in-hospital course was complicated by mediastinitis
n 4 of 6 patients leading to fatal sepsis in 2 of them.
ecurrent hematemesis occurred in the remaining 4 patients
nd was fatal in all of them (Fig. 1, Table 1). All patients
ied median 53 (20 to 221) days after readmission.
iscussion
e report the occurrence of AEF as an unusual, cata-
trophic complication of TEVAR, which is rare, occurring
n 1.9% of TEVAR patients in our series and is thus
robably not widely known within the medical community.
hese were encountered within 1 to 16 months after
EVAR, presenting either as hematemesis or new-onset
epsis. While presentation of AEF as hematemesis is
ntuitive, our experience suggests that AEF may also man-
fest as a new-onset fever accompanied by elevated markers
C
F
ing the characteristic appearance of an aortoesophageal ﬁstula with evi-
). Please note air entrapment within the thrombosed aneurysm/dissection in) show
terisksf inflammation, and may herald the onset of eminent
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574upture of aorta into the esophagus. Thus, not only hemate-
esis but new-onset fever in patients with prior TEVAR
hould alert the physician to this potentially life-threatening
omplication of TEVAR.
AEF is a rare cause of upper gastrointestinal bleeding
ith etiologies including foreign body ingestion, malig-
ancy, and post-operative trauma, but is often described in
ardiovascular literature as being associated with penetrating
r ruptured TAAs (9). Secondary AEF is well recognized as
complication of thoracic aortic surgery and has cata-
trophic consequences without treatment (10). It may also
rise as aortoenteric fistula after open abdominal aortic
urgery with an estimated incidence of 0.4% to 4% of
atients (11,12). Few case reports, most with single cases,
ave also highlighted the risk of AEF after less invasive
EVAR procedures (11,13–15). The primary clinical pre-
entation is uncontrolled hematemesis, usually resulting in
xsanguination.
CT in our experience was particularly helpful in the
atients as an initial modality, because evidence of a
elatively characteristic new heterogeneous mass between
he DTA and esophagus with or without air entrapment
ave an early clue to the diagnosis. It is likely that in patients
resenting with new-onset fever after TEVAR a CT per-
ormed early on with a finding of a new mass between the
orta and esophagus may provide an early clue that could
hen further be confirmed by prompt EGD. While AEF
as directly visualized by EGD as large esophageal defects
ith a clear view onto the stent-graft in 4 patients, the
Figure 2. Aspect of Aortoesophageal Fistula on
Esphago-Gastro-Duodenoscopy
Esophago-gastro-duodenoscopy demonstrating large aortoesophageal ﬁs-
tula with an apparent view onto the intact aortic stent-graft.ndings of only mild erosive lesions in the other 2 precludedarly diagnosis in the other 2, 1 of whom was discharged
ome, only to present later with fatal hematemesis. None-
heless, in retrospect when looking at all patients with this
omplication, it was clear that presence of new-onset fever
r hematemesis together with findings of CT and EGD,
hen put together, would, in the context of previous
EVAR, have resulted in early diagnosis. Particularly, in
he 2 patients who only had mild erosive lesions in their
sophagus on EGD, recognition of this to be associated
ith AEF may have prompted early triage and/or surgical
epair before development of ulcer and hematemesis, and
ay have had the potential for better outcomes. However,
his theory needs to be proven in the future.
Published reports have confirmed that conservative man-
gement to control rebleeding and prevent mediastinitis is
lmost invariably a fatal outcome, potentially justifying a
ore aggressive surgical strategy involving esophageal re-
ection, effective debridement, and aortic (homo)graft in-
erposition (13,16). However, operative management of
EF carries significant mortality and is frequently compli-
ated by mediastinitis, sepsis, and hemorrhage. It is impor-
ant to recognize that the majority of our patients initially
nderwent TEVAR, because their general health status and
omorbidities precluded open surgical repair. Therefore, the
ajority of our AEF patients were treated conservatively,
ecause surgical repair was prohibitive due to their general
ealth condition and frailty. Conservative management
ncluded the use of broad-spectrum antibiotics, proton
ump inhibition, and enteral feeding via percutaneous
Figure 3. Fatal Bleeding of Aortoesophageal FistulaEsophago-gastro-duodenoscopy during fatal rebleeding in Patient #6 (H.T.).
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575ndoscopic gastrostomy (PEG) to unburden the esophageal
esion. Although outcome was fatal in all patients, at least 2
atients could be stabilized by using these conservative
easures for 6 months. In 3 patients, self-expanding
sophageal stents were placed to promote healing and
revent rebleeding. However, in none of these patients
ealing of the esophageal fistula was ultimately observed on
ontrol EGD. In fact, all of these patients developed fatal
ebleeding. Surgical repair was performed in a single case,
ut was complicated by mediastinitis and graft infection
equiring revision surgery. A recent report suggested a
urgical approach focused on the esophageal pathology and
ot on the potential infectious stent-graft in order to limit
he extent of surgery in these ill patients (13). Recently,
ndovascular stent-graft placement also has been success-
ully used to treat secondary AEF after surgery (17,18). We
lso attempted re-TEVAR in a single patient, who later
ied. However, restent-grafting into a potentially contam-
nated or infected environment remains counterintuitive and
ebatable. So far, it is not completely understood whether
he severe bleeding in AEF arises from esophageal vessels or
ortic vasa vasorum or directly from the aorta. In all of our
atients, the stent-graft itself was intact, rendering bleeding
irectly from the aorta somewhat unlikely. Therefore, it is
uestionable whether re-TEVAR will control the bleeding
isk of AEF.
The exact pathophysiologic mechanisms of AEF forma-
ion secondary to TEVAR are unknown, so far. We were
ot able to identify anatomic or procedural similarities
mong our patients that may have predisposed to AEF.
ypotheses include: 1) direct erosion of the relatively rigid
tent-graft through the aorta into the esophagus; 2) pressure
ecrosis of the esophageal wall due to the continuing forces
f the self-expanding endoprosthesis; 3) ischemic esopha-
eal necrosis due to stent-graft coverage of aortic side
ranches that feed the esophagus; and 4) infection of
tent-graft prosthesis that eventually extends to the esoph-
gus eroding its wall (11). The last 2 concepts may be
upported by our observation that AEF did not show any
ealing tendency despite prolonged sealing by esophageal
tents in 3 patients. Until further research in large number
f patients will hopefully allow identification of patients at
isk, close surveillance of all patients after TEVAR is
andatory. New-onset fever with elevated inflammatory
arkers and/or hematemesis with homogenous masses with
r without air entrapment on CT should raise suspicion of
EF prompting immediate endoscopic evaluation.
onclusions
n summary, our case series indicates that AEF after
EVAR is a rare unusual complications of TEVAR (inci-
ence1.9%) that occurs relatively early after the procedure
nd is uniformly fatal. Additionally, these data indicate thatot only hematemesis, but fever and heightened inflamma-
ory markers, should raise the clinical suspicion for AEF in
atients with prior TEVAR. CT is an attractive initial tool
articularly among those presenting with fever with upper
astrointestinal endoscopy, providing the eventual confir-
ation of the diagnosis. Most conservative strategies, in-
luding the use of broad-spectrum antibiotics, proton pump
nhibitors, and enteral feeding, remain far from optimal for
he management of this condition highlighting the need for
urther research in this area not only for identifying patients
t risk, but also evaluating strategies for better management.
ost importantly, as TEVAR use grows, physicians in the
eneral community should be aware of AEF as one of the
ifferential diagnoses in TEVAR patients presenting with
ommonly encountered symptoms of fever or hematemesis.
his would allow prompt diagnosis and/or immediate triage
or treatment.
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